U.S. flag

An official website of the United States government

NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr) AND Charcot-Marie-Tooth disease X-linked recessive 4

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Dec 10, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000789722.6

Allele description [Variation Report for NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)]

NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)

Genes:
RAB33A:RAB33A, member RAS oncogene family [Gene - OMIM - HGNC]
AIFM1:apoptosis inducing factor mitochondria associated 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq26.1
Genomic location:
Preferred name:
NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)
HGVS:
  • NC_000023.11:g.130137134A>G
  • NG_013217.1:g.33700T>C
  • NM_001130846.4:c.2T>C
  • NM_001130847.4:c.*247T>C
  • NM_004208.4:c.1019T>CMANE SELECT
  • NM_145812.3:c.1007T>C
  • NP_001124318.2:p.Met1Thr
  • NP_004199.1:p.Met340Thr
  • NP_665811.1:p.Met336Thr
  • NC_000023.10:g.129271109A>G
  • NM_004208.3:c.1019T>C
  • NR_132647.2:n.1264T>C
Protein change:
M1T; MET340THR
Links:
OMIM: 300169.0015; dbSNP: rs1057518895
NCBI 1000 Genomes Browser:
rs1057518895
Molecular consequence:
  • NM_001130847.4:c.*247T>C - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001130846.4:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001130846.4:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004208.4:c.1019T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145812.3:c.1007T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_132647.2:n.1264T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Charcot-Marie-Tooth disease X-linked recessive 4 (CMTX4)
Synonyms:
Cowchock syndrome; CMTX 4; Neuropathy, axonal motor-sensory with deafness and mental retardation; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010689; MedGen: C0795910; Orphanet: 101078; OMIM: 310490

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000929099Inherited Neuropathy Consortium
no assertion criteria provided
Uncertain significancegermlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001052585OMIM
no assertion criteria provided
Pathogenic
(Dec 10, 2019)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.

Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu YF, McSweeney KM, Ben-Zeev B, Nissenkorn A, Anikster Y, Oz-Levi D, Dhindsa RS, Hitomi Y, Schoch K, Spillmann RC, Heimer G, Marek-Yagel D, Tzadok M, Han Y, Worley G, Goldstein J, Jiang YH, Lancet D, et al.

Genet Med. 2015 Oct;17(10):774-81. doi: 10.1038/gim.2014.191. Epub 2015 Jan 15.

PubMed [citation]
PMID:
25590979
PMCID:
PMC4791490

Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin.

Heimer G, Eyal E, Zhu X, Ruzzo EK, Marek-Yagel D, Sagiv D, Anikster Y, Reznik-Wolf H, Pras E, Oz Levi D, Lancet D, Ben-Zeev B, Nissenkorn A.

Eur J Paediatr Neurol. 2018 Jan;22(1):93-101. doi: 10.1016/j.ejpn.2017.09.004. Epub 2017 Sep 15.

PubMed [citation]
PMID:
28967629
See all PubMed Citations (3)

Details of each submission

From Inherited Neuropathy Consortium, SCV000929099.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From OMIM, SCV001052585.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a 17-year-old boy (patient 1) with X-linked recessive Charcot-Marie-Tooth disease-4 with cerebellar ataxia (CMTX4; 310490), Heimer et al. (2018) identified a c.1019T-C transition in the AIFM1 gene, resulting in a met340-to-thr (M340T) substitution at a highly conserved residue close to the NAD binding site. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was inherited from the unaffected mother. It was filtered against the dbSNP (build 138), 1000 Genomes Project, Exome Sequencing Project, and ExAC databases, as well as in-house controls. Functional studies of the variant and studies of patient cells were not performed.

In 7 affected males from a multigenerational Irish family with CMTX4 with cerebellar ataxia, Bogdanova-Mihaylova et al. (2019) identified a hemizygous M340T mutation. The mutation, which was found by whole-genome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Functional studies of the variant and studies of patient cells were not performed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 15, 2024